Stryker Rejuvenate Hip Replacement Failure Lawyers

Unlike hip implants using a metal-on-metal design, Stryker Corporation incorporated ceramic components into its Rejuvenate hip implant device. Despite the differences, however, Rejuvenate patients are nevertheless experiencing similar injuries.

Metal-on-Metal Hip Implant Designs

Like the bones that comprise one’s hip, implants are designed around a ball and socket configuration. Some manufacturers such as Johnson & Johnson’s DePuy division, Wright Technologies, and Smith and Nephew were forced to issue recalls of their products when fretting and corrosion caused tissue damage, metallosis (metal poisoning), and other unintended side effects. An estimated 500,000 patients received metal-on-metal hip implants, and because of the high rate of failure, many have sought damages in court.

Strkyer Rejuvenate Hip Implant

Stryker’s Rejuvenate product was intended to be an alternative to the metal-on-metal devices, and the company promoted it as a modular, custom-fit hip replacement offering a better range of motion – a particularly strong selling point to younger patients. Although the ceramic components in the ball and socket don’t present the same dangers as metal-on-metal designs, the metal surfaces in the neck and stem can rub against one another, causing metallic debris to come loose and impact the surrounding area.

Approved for sale in the U.S. in 2008, the Rejuvenate device was implanted in an estimated 20,000 patients before Stryker issued a recall in July 2012 that also included its ABG II product, another modular stem design. Typically, hip implants are expected to last 15 to 20 years, but some Rejuvenate patients suffered failure after only five years. Stryker Rejuvenate Hip Replacement causes conditions such as metallosis (metal poisoning), inflammatory reactions, and tissue damage, and victims may suffer from:

• Decreased mobility
• Severe pain in the hip, groin or thigh
• Inflammation and swelling
• Hip joint dislocation
• Hip joint infection

Stryker announced a voluntary recall of the Rejuvenate hip implant in July 2012, along with another device called the ABG II. The company indicated that its decision was based upon the potential for fretting and corrosion at the modular neck junction which may lead to adverse local tissue reactions.

If you or someone you know is experiencing complications after receiving a Stryker Rejuvenate of ABG II hip replacement, the time you have to protect your rights and seek appropriate compensation is limited. Sommers Schwartz attorneys are experienced trial lawyers who will and have gone toe-to-toe with big name medical device manufacturers on behalf of clients who’ve placed their trust in us.

Call the defective device attorneys at Sommers Schwartz today to discuss your case and learn how we can
help.